Login to Your Account



Startup Harbour Biomed adds $50M in series A, snags antibody platform

By Shannon Ellis
Staff Writer

Thursday, December 22, 2016

SHANGHAI – Newly founded biopharma Harbour Biomed Therapeutics Ltd., of Shanghai, has acquired privately held Harbour Antibody BV, of Cambridge, Mass.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription